Tag: lung carcinoma

Three years ago, oncologist Charles Canaan Williams, Jr, a lung cancer specialist and a senior member of the Thoracic Oncology Program at Moffitt Cancer Center, Tampa, Florida, was killed when an orange Dodge Charger flew through a stoplight at 95 mph and slammed into his car. The driver of the car, Igbinosa Oghubor, was subsequently

The US Food and Drug Administration (FDA) today granted an accelerated approval for amivantamab (Rybrevant) as the first targeted treatment for patients with non–small cell lung cancers (NSCLC) harboring epidermal growth factor receptor (EGFR) exon 20 insertion mutations. The FDA also approved the Guardant360 CDx as a companion diagnostic for the new drug. “With today’s